Hitachi Kokusai Electric

Hitachi Kokusai Electric is a specialized technology firm that provides advanced automation solutions for the life sciences, particularly in the field of regenerative medicine. The company leverages its heritage in high-precision engineering to develop integrated systems for the automated culture, expansion, and evaluation of therapeutic cells, including induced pluripotent stem cells (iPSCs). Their flagship iACE platform is designed to standardize complex cell production processes, enabling high-quality, scalable manufacturing for clinical and commercial applications. By integrating semiconductor-grade cleanroom technology with sophisticated imaging and robotics, Hitachi Kokusai Electric supports the industrialization of cell-based therapies. The company operates as an independent entity under the ownership of KKR, focusing on bridging the gap between laboratory research and large-scale therapeutic production.